Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
Related posts
-
Weppner’s 3 TD night helps Geneva snap long losing skid to Batavia
Geneva wide receiver Finnegan Weppner had three touchdowns in the second half to lead the Vikings... -
Fremd QB’s historic night leads Vikings over Barrington
Fremd southpaw QB Danny O'Brien threw for a school-record 395 yards, breaking the record of Chicago... -
One year later: Specter of Oct. 7 hovers over High Holiday celebrations
Suburban Jews reflect on the anniversary of the Oct. 7 Hamas attacks in Israel while observing...